Preventing psoriatic arthritis: is disease interception the next frontier in clinical pharmacology?

Kougkas N, Fragoulis G

Open source

DOI
10.1080/17512433.2026.2737173
Published
2026 Sep 21
Container
Expert review of clinical pharmacology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1080/17512433.2026.2737173,
  title = {Preventing psoriatic arthritis: is disease interception the next frontier in clinical pharmacology?},
  author = {Kougkas N and Fragoulis G},
  year = {2026},
  journal = {Expert review of clinical pharmacology},
  doi = {10.1080/17512433.2026.2737173},
  url = {https://doi.org/10.1080/17512433.2026.2737173}
}

RIS

TY  - JOUR
TI  - Preventing psoriatic arthritis: is disease interception the next frontier in clinical pharmacology?
AU  - Kougkas N
AU  - Fragoulis G
PY  - 2026
JO  - Expert review of clinical pharmacology
DO  - 10.1080/17512433.2026.2737173
UR  - https://doi.org/10.1080/17512433.2026.2737173
ER  - 

APA

N, K., & G, F. (2026). Preventing psoriatic arthritis: is disease interception the next frontier in clinical pharmacology?. Expert review of clinical pharmacology. https://doi.org/10.1080/17512433.2026.2737173

Source records